Glenmark Pharmaceuticals Ltd

NSE: GLENMARK · BSE: 532296 · Pharmaceuticals & Biotechnology · 39 announcements

Glenmark Pharmaceuticals Ltd news stories on ALFA NewsRead the news →

Share price: ₹2,293.50
Market cap: ₹64,728 Cr
Revenue (annual): ₹16,983 Cr
Net profit (annual): ₹1,362 Cr
P/E (TTM): 36.0×Sector 47.4×
Promoter holding: 46.65%+0.00% QoQ
FII holding: 20.89%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Product Launch 3 Earnings Call 3 Other Announcement 2 Business Update 2 Annual General Meeting 2 Results Update 1 Regulatory Approval 1 Legal & Regulatory 1 Financial Results 1 Employee Stock Options 1 Credit Rating 1 Board Meeting Date 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

10 Aug 2026 15:00 IST NSE

Employee Stock Options

Glenmark Pharmaceuticals Employee Stock Options

Glenmark Pharmaceuticals Limited has allotted 23,863 equity shares following the exercise of options under its ESOP 2016 scheme. This allotment increases the company's paid-up capital to Rs. 28,22,24,672.

Read the filing ↗